Is NGNE or NRSN more undervalued in 2026?

CirclFi compares Neurogene Inc. (NGNE) and NeuroSense Therapeutics Ltd. (NRSN) using 13 institutional-grade valuation models. NGNE has a Quality of Company score of 5.2/10 while NRSN scores 3.8/10.

Which is a better buy — NGNE or NRSN?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do NGNE and NRSN valuations compare?

NGNE at $28.34 and NRSN at $0.82 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

NGNE vs NRSN Valuation Comparison 2026 — Intrinsic Value Analysis

NGNE

Pharmaceutical Preparations

Neurogene Inc.

Quality

5.2

out of 10

Value Trap

SAFE

Price

$28.34

Last close

Models

9/13

Active

NRSN

Pharmaceutical Preparations

NeuroSense Therapeutics Ltd.

Quality

3.8

out of 10

Value Trap

SAFE

Price

$0.82

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	NGNE Fair Value	NGNE Upside	NRSN Fair Value	NRSN Upside
Bayesian DCF	Intrinsic	$11.44	-59.6%	$0.23	-72.1%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$16.56	-41.6%	$0.21	-74.3%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for NGNE vs NRSN — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

NGNE vs NRSN — Which Stock Is More Undervalued?

NGNE scores higher with a 5.2/10 quality rating vs NRSN's 3.8/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Neurogene Inc. (NGNE) and NeuroSense Therapeutics Ltd. (NRSN) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

NGNE currently trades at $28.34 with a QOC of 5.2/10, while NRSN trades at $0.82 with a QOC of 3.8/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).